Journal Title：Biodrugs

An essential resource for R&D professionals and clinicians with an interest in biologic therapies.

BioDrugs covers the development and therapeutic application of biotechnology-based pharmaceuticals and diagnostic products for the treatment of human disease.

BioDrugs offers a range of additional enhanced features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist patients, caregivers and others in understanding important medical advances. The journal also provides the option to include various other types of enhanced features including slide sets, videos and animations. All enhanced features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager?, supported by a database of international experts. This database is shared with other Adis journals.

對生物療法感興趣的研發(fā)專業(yè)人員和臨床醫(yī)生的重要資源。

BioDrugs 涵蓋了用于治療人類疾病的生物技術(shù)藥物和診斷產(chǎn)品的開發(fā)和治療應(yīng)用。

BioDrugs 提供了一系列額外的增強功能，旨在提高期刊內(nèi)容的可見性、讀者群和教育價值。每篇文章都附有要點摘要，為廣大讀者提供內(nèi)容的省時概述。文章可能附有通俗易懂的語言摘要，以幫助患者、護(hù)理人員和其他人了解重要的醫(yī)學(xué)進(jìn)展。該期刊還提供包括幻燈片集、視頻和動畫等各種其他類型的增強功能的選項。所有增強功能都經(jīng)過同行評審，標(biāo)準(zhǔn)與文章本身一樣高。同行評審使用 Editorial Manager? 進(jìn)行，由國際專家數(shù)據(jù)庫支持。該數(shù)據(jù)庫與其他 Adis 期刊共享。

Biodrugs創(chuàng)刊于1994年，由Springer International Publishing出版商出版，收稿方向涵蓋免疫學(xué) - 醫(yī)學(xué)全領(lǐng)域，此刊是該細(xì)分領(lǐng)域中屬于非常不錯的SCI期刊，在行業(yè)細(xì)分領(lǐng)域中學(xué)術(shù)影響力較大，專業(yè)度認(rèn)可很高，所以對原創(chuàng)文章要求創(chuàng)新性較高，如果您的文章質(zhì)量很高，可以嘗試。平均審稿速度 12周，或約稿 ，影響因子指數(shù)5.4，該期刊近期沒有被列入國際期刊預(yù)警名單，廣大學(xué)者值得一試。